Bio-Techne Corporation (TECH)

NMS – Real Time Price. Currency in USD

47.42

0.00 (0.00%)

At close: May 12, 2026, 4:00 PM EDT

47.35

-0.07 (-0.15%)

Pre-market: May 13, 2026, 8:32 AM EDT

12.05.2026

Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

06.05.2026

Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript

06.05.2026

TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up

Bio-Techne slips after Q3 EPS miss and revenue decline, despite operating margin expansion and strong growth in key segments.

06.05.2026

Techne (TECH) Misses Q3 Earnings and Revenue Estimates

Techne (TECH) came out with quarterly earnings of $0.53 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.56 per share a year ago.

06.05.2026

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

Biotech firm Bio-Techne on Wednesday missed Wall Street estimates for third-quarter revenue, as cuts to U.S. academic funding weighed on demand for its drug-development ‌products.

06.05.2026

Bio-Techne Declares Dividend

MINNEAPOLIS, May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2026. The quarterly dividend will be payable May 29, 2026, to all common shareholders of record on May 18, 2026.

06.05.2026

Bio-Techne Releases Third Quarter Fiscal 2026 Results

MINNEAPOLIS, May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2026. Third Quarter FY2026 Highlights Reported and organic revenue declined 2% to $311.4M, negatively impacted by prior‑year GMP fast‑track orders and timing of large Commercial Supply shipments GAAP EPS increased to $0.32 from $0.14; adjusted EPS was $0.53, down from $0.56 Large pharma delivered the sixth consecutive quarter of double‑digit growth, offset by a continued lag in spending by emerging biotech; U.S. academic markets stabilized with low‑single‑digit growth Growth vectors performed well, with mid‑single‑digit growth in Proteomic Analysis instruments, mid‑teens growth in Spatial Biology, and nearly 50% growth in GMP proteins excluding fast‑track customers "The Bio‑Techne team delivered solid execution amid a mixed end‑market environment," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne.

Videos

No Data

There is no data to display

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The new brand structure reflects the scientific journey, connecting early discoveries to translational insight to clinical decision-making.

25.03.2026

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and enhanced layered amplification (seqLA™) technology enabling improved detection of low-abundance and challenging targets.

Bio-Techne Corporation (TECH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bio-Techne Corporation (TECH)

Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript

TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up

Techne (TECH) Misses Q3 Earnings and Revenue Estimates

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

Bio-Techne Declares Dividend

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Videos

No Data

Press releases

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Bio-Techne Declares Dividend

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript

TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up

Techne (TECH) Misses Q3 Earnings and Revenue Estimates

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

Bio-Techne Declares Dividend

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Videos

No Data

Press releases

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Bio-Techne Declares Dividend

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

Search stocks

Bio-Techne Corporation (TECH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bio-Techne Corporation (TECH)

Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript

TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up

Techne (TECH) Misses Q3 Earnings and Revenue Estimates

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

Bio-Techne Declares Dividend

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Videos

No Data

Press releases

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Bio-Techne Declares Dividend

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript

TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up

Techne (TECH) Misses Q3 Earnings and Revenue Estimates

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

Bio-Techne Declares Dividend

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Videos

No Data

Press releases

Bio-Techne Releases Third Quarter Fiscal 2026 Results

Bio-Techne Declares Dividend

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite